FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...
PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...
LONDON — AcrySof IOLs with a 6-mm optic diameter were associated with less posterior capsular opacification than smaller-diameter IOLs of the same model in a study performed here. Posterior capsule ...
PanOptix, the first and only advanced trifocal lens for U.S. patients undergoing cataract surgery, will be showcased in educational events and clinical data presentations First-ever analyses on IOLs ...
Forty-four eyes of 33 patients underwent routine phacoemulsification cataract surgery with in-the-bag implantation of a toric AcrySof IOLs. Seven eyes were implanted with the SA60T3 IOL, 17 eyes were ...
Slit lamp photo of the ReStor IOL in the eye. (All images courtesy of Francesco Carones, MD.) BARCELONA – The apodized optic design of the pseudoaccomodative Alcon AcrySof ReStor IOL may overcome the ...
Basel, Switzerland, July 1, 2015 – Alcon, the global leader in eye care and a division of Novartis, has received European CE Mark for its AcrySof® IQ Aspheric IOL with the UltraSert™ Pre-loaded ...
Background: To use a Monte Carlo simulation to predict postoperative results with the AcrySof ® Toric lens, evaluating the likelihood of over- or under-correction using various toric lens selection ...
SAN FRANCISCO (MarketWatch) -- Alcon Inc. said Wednesday after the closing bell that the Food and Drug Administration has granted approval for its intraocular lens, AcrySof ReSTOR, to be used by ...
PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results